Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction.MapLight Therapeutics announced a $225 million Series C financing co-led by Novo Holdings, 5AM Ventures, Cowen Healthcare…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
